SEBI Bans Ex-Wockhardt Executive From Securities Market For Six Months
Yatendra Kumar is also prohibited from buying, selling, or engaging in any transactions involving Wockhardt.
Stay updated with breaking news from Pharma Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Yatendra Kumar is also prohibited from buying, selling, or engaging in any transactions involving Wockhardt.
Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge losses of over Rs 14 lakh averted by flouting insider trading rules.
Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge losses of over Rs 14 lakh averted by flouting insider trading rules.
Burning Rock Biotech Limited (NASDAQ:BNR – Get Rating) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 665,100 shares, a growth of 9.4% from the May 15th total of 608,200 shares. Currently, 0.8% of the company’s stock are sold short. […]
Diametric Capital LP cut its holdings in Burning Rock Biotech Limited (NASDAQ:BNR – Get Rating) by 71.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 92,204 shares of the company’s stock after selling 227,554 shares during the quarter. Diametric Capital LP’s holdings in Burning Rock Biotech were worth $207,000 as of its most […]